Depressive Symptoms in Ophthalmology Patients

Rabins, Peter V.

doi:10.1001/jamaophthalmol.2016.2367

Cited by 4 publications

(4 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Clinicians might consider using the VAQ or a single VAQ item to assess the patient’s glaucoma burden and possible related depression. In keeping with Rabins’ advice, 34 continued assessment and management of patients’ anxiety about glaucoma is a necessary addition to the standard clinical reminders about the importance of treatment adherence. Signs of depression, even if unrelated to glaucoma, can lead to low medication adherence and warrant referral for care by a qualified health care professional.…”

Section: Discussionmentioning

confidence: 93%

Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS)

Musch

Niziol

Janz

et al. 2019

American Journal of Ophthalmology

View full text Add to dashboard Cite

Purpose To characterize longitudinal trends and factors predictive of depressive symptoms following glaucoma diagnosis in Collaborative Initial Glaucoma Treatment Study (CIGTS) participants. Design: Cohort study using follow up data from a clinical trial. Methods 607 participants with newly-diagnosed open-angle glaucoma were enrolled at 14 clinical centers in the United States from October 1993 through April 1997, randomized to treatment with medication or surgery, and followed every 6 months through 2004.The 8-item Center for Epidemiologic Studies Depression Scale (CES-D) was administered at baseline and follow-up visits. Three outcome measures were investigated: overall CES-D depression score, presence of mild or worse depression (CES-D score≥7), and number of depressive symptoms endorsed. Results The average baseline CES-D score was 2.4 (SD=3.8), 12.5% of subjects reported symptomatology associated with mild or worse depression, and 55.3% reported at least one depressive symptom. By one-year post-treatment, depression measures decreased (1.5, 6.7%, and 38.4%, respectively), with modest decreases thereafter. Baseline factors predictive of mild or worse depression included worse vision-related quality of life (VRQOL) (odds ratio, OR=2.41), female sex (OR=1.42), younger age (OR per 10 years younger=1.24), and

show abstract

Section: Discussionmentioning

confidence: 93%

Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS)

Musch

Niziol

Janz

et al. 2019

American Journal of Ophthalmology

View full text Add to dashboard Cite

show abstract

“…In clinical practice, depressive symptoms are common among patients with eye disease, with a pooled prevalence of 25% (range 5.4–57%) 5 , 6 . However, depression is often left unrecognised or untreated in the ophthalmological clinic, which can negatively affect therapy outcomes and quality of life 5 , 7 . Previous studies have suggested the correlation between depression and visual impairment 8 , 9 .…”

Section: Introductionmentioning

confidence: 99%

Cataract and the increased risk of depression in general population: a 16-year nationwide population-based longitudinal study

Chen

Liu

Lin

et al. 2020

Sci Rep

View full text Add to dashboard Cite

Cataract is the primary cause of visual impairment and can be corrected by cataract surgery. We investigated the impact of cataract on the risk of depression along with the benefits of cataract surgery. Patients newly diagnosed with cataract by ophthalmologists between 2001 and 2015 were identified from the National Health Insurance Research Database (NHIRD) in Taiwan. Non-cataract individuals were recruited by 1:1 matching for age, sex and index year. After propensity score matching, 233,258 patients in total were included in our study: 116,629 in each of the cataract and non-cataract cohorts. The primary outcome was the new diagnosis of depression by psychiatrists. In a mean follow-up period of 7.8 years, cataract was significantly associated with increased risk of developing depression (adjusted hazard ratio [aHR] = 1.78, 95% confidence interval [CI] 1.70–1.87, p < 0.001). We further divided the cataract cohort into surgery and non-surgery groups. Notably, cataract surgery group was associated with a decreased risk of depression compared with non-surgery patients (aHR = 0.75, 95% CI 0.71–0.79, p < 0.001). Our results emphasise the importance of regular screening for depression among cataract patients and the beneficial effect of cataract surgery in reducing the risk of depression.

show abstract

“…In Group 1, the median score of depression subscale was 10 (4-17), and the median score of anxiety sub-scale was 9 (5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). In Group 2, the median score of depression subscale was 5 (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15), and the median score of anxiety subscale was 4 (0-11) (P=0.007, P<0.001, respectively) (Table 2).…”

Section: Resultsmentioning

confidence: 99%

“…However, the diagnosis of depression cannot be made by ophthalmologic outpatient clinics, and this may cause reduction in patients' treatment compliance and their life quality. [14,15] Although several studies that vision impairment itself can potentially be the cause for depression and anxiety in older population, [15,16] the exact relationship between cataracts, depression, and anxiety remains unclear. However, visual impairment due to senile cataracts is likely to negatively impact patient's daily activities, including their physical and intellectual activities, such as reading or communicating with other people, causing individual isolation, and potentially leading to depression.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of existence of depression or anxiety symptoms in patients with bilateral cataract

Kiyat

2023

Eur Eye Res

View full text Add to dashboard Cite

The purpose of this study was to evaluate if patients with bilateral cataract are more likely to have depression or anxiety symptoms when compared to age-and sex-matched volunteers who had already undergone bilateral uncomplicated cataract surgery in both eyes. Methods: Twenty patients who were diagnosed to have senile cataract in both eyes were included in the study. Furthermore, twenty volunteers who had already undergone bilateral uncomplicated cataract surgery were included. Patients with bilateral cataract were defined as "Group 1, " and volunteers with bilateral artificial monofocal intraocular lenses in the posterior chamber were defined as "Group 2. " Both Group 1 and Group 2 completed the "Hospital Anxiety and Depression Scale (HADS)" questionnaire. The scale was used to determine the anxiety and depression symptoms. Results: According to the HAD scale, in Group 1, 6 patients were detected as having mild depression symptoms, 2 moderate, and 6 severe. Furthermore, in Group 1, 5 patients were detected as having mild anxiety symptoms, 2 moderate, and 4 severe. In Group 1, high HAD scale scores were detected, which suggests a propensity toward depression and anxiety when compared to Group 2 (P=0.007, P<0.001, respectively). Conclusion: In our study, in patients diagnosed with bilateral senile cataract, high scores were detected with the HAD scale. Ophthalmologists should be familiar with the possibility of tendency of senile cataract patients to depression or anxiety and consider screening these patients for these symptoms and consider referring for counseling. Furthermore, psychiatrists could ask their patients about their visual acuity condition and refer them to an ophthalmologist to plan a timely surgery for cataract.

show abstract

Depressive Symptoms in Ophthalmology Patients

Cited by 4 publications

References 5 publications

Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS)

Trends in and Predictors of Depression Among Participants in the Collaborative Initial Glaucoma Treatment Study (CIGTS)

Cataract and the increased risk of depression in general population: a 16-year nationwide population-based longitudinal study

Evaluation of existence of depression or anxiety symptoms in patients with bilateral cataract

Contact Info

Product

Resources

About